Literature DB >> 26624606

Transjugular Intrahepatic Portosystemic Shunt Combined with Haemoperfusion in an End-stage Renal Disease Patient with Liver Cirrhosis-related Refractory Portal Hypertensive Variceal Bleeding: A Case Report.

L Li1, T L Cui1, X Li2, F Liu3.   

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is recommended as the second-line option for variceal bleeding in liver cirrhosis patients when the bleeding is not well controlled by medical and/or endoscopic therapy. However, due to a high incidence of post-TIPS hepatic encephalopathy, particularly in patients with end-stage renal disease (ESRD), TIPS is rarely used in such cases. We report a case involving the successful and safe use of TIPS combined with haemoperfusion to treat an ESRD patient with liver cirrhosis-related refractory portal hypertensive variceal bleeding. Our case suggests the possibility of inserting TIPS to stop recurrent variceal bleeding in ESRD patients with liver cirrhosis. Haemoperfusion may be used to reduce the risk of post-TIPS hepatic encephalopathy.

Entities:  

Year:  2015        PMID: 26624606      PMCID: PMC4909088          DOI: 10.7727/wimjopen.2015.157

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  9 in total

Review 1.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

Review 2.  Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review.

Authors:  Xing-Shun Qi; Ming Bai; Zhi-Ping Yang; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

3.  A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.

Authors:  Agustín Albillos; Rafael Bañares; Mónica González; María-Vega Catalina; Luis-Miguel Molinero
Journal:  J Hepatol       Date:  2005-07-05       Impact factor: 25.083

4.  Kidney plays a major role in ammonia homeostasis after portasystemic shunting in patients with cirrhosis.

Authors:  Steven W M Olde Damink; Cornelis H C Dejong; Nicolaas E P Deutz; Doris N Redhead; Peter C Hayes; Peter B Soeters; Rajiv Jalan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-02-02       Impact factor: 4.052

5.  Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience.

Authors:  Curtis L Anderson; Wael E A Saad; Sean D Kalagher; Steven Caldwell; Saher Sabri; Ulku C Turba; Alan H Matsumoto; John F Angle
Journal:  J Vasc Interv Radiol       Date:  2010-08-05       Impact factor: 3.464

Review 6.  TIPS: 25 years later.

Authors:  Martin Rössle
Journal:  J Hepatol       Date:  2013-06-25       Impact factor: 25.083

7.  Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.

Authors:  Ziv J Haskal; Jai Radhakrishnan
Journal:  J Vasc Interv Radiol       Date:  2008-04       Impact factor: 3.464

Review 8.  Prophylactic use of transjugular intrahepatic portosystemic shunt aids in the treatment of refractory ascites: metaregression and trial sequential meta-analysis.

Authors:  Ren Pin Chen; Xiao Ju Zhu Ge; Zhi Ming Huang; Xiao Hua Ye; Chang Yuan Hu; Guang Rong Lu; De Yi Lu; Igor Longe Phemba
Journal:  J Clin Gastroenterol       Date:  2014-03       Impact factor: 3.062

9.  The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status.

Authors:  Gilles Pomier-Layrargues; Louis Bouchard; Michel Lafortune; Julien Bissonnette; Dave Guérette; Pierre Perreault
Journal:  Int J Hepatol       Date:  2012-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.